z-logo
open-access-imgOpen Access
Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer
Author(s) -
Rachel Evans,
Fabián Flores-Borja,
Sissiri,
Elena Miranda,
Katherine Lawler,
Anita Grigoriadis,
James Monypenny,
Cheryl Gillet,
Julie Owen,
Peter M. Gordon,
Victoria Male,
Anthony Cheung,
Farzaoor,
Paul R. Barber,
Rebecca Marlow,
Erika Francesch-Domenech,
Gilbert O. Fruhwirth,
Mario Leonardo Squadrito,
Borivoj Vojnovic,
Andrew Tutt,
Frederic Festy,
Michele De Palma,
Tony Ng
Publication year - 2019
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2019.04.076
Subject(s) - cancer research , integrin , metastasis , rhoa , microbiology and biotechnology , cell adhesion , macrophage , biology , signal transduction , chemistry , medicine , cancer , cell , biochemistry , genetics , in vitro
Lymphatic vasculature is crucial for metastasis in triple-negative breast cancer (TNBC); however, cellular and molecular drivers controlling lymphovascular metastasis are poorly understood. We define a macrophage-dependent signaling cascade that facilitates metastasis through lymphovascular remodeling. TNBC cells instigate mRNA changes in macrophages, resulting in β4 integrin-dependent adhesion to the lymphovasculature. β4 integrin retains macrophages proximal to lymphatic endothelial cells (LECs), where release of TGF-β1 drives LEC contraction via RhoA activation. Macrophages promote gross architectural changes to lymphovasculature by increasing dilation, hyperpermeability, and disorganization. TGF-β1 drives β4 integrin clustering at the macrophage plasma membrane, further promoting macrophage adhesion and demonstrating the dual functionality of TGF-β1 signaling in this context. β4 integrin-expressing macrophages were identified in human breast tumors, and a combination of vascular-remodeling macrophage gene signature and TGF-β signaling scores correlates with metastasis. We postulate that future clinical strategies for patients with TNBC should target crosstalk between β4 integrin and TGF-β1.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom